Reza Oliyai

2.4k total citations · 1 hit paper
21 papers, 1.8k citations indexed

About

Reza Oliyai is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Reza Oliyai has authored 21 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Infectious Diseases and 5 papers in Organic Chemistry. Recurrent topics in Reza Oliyai's work include Protein purification and stability (7 papers), HIV/AIDS drug development and treatment (7 papers) and RNA Interference and Gene Delivery (5 papers). Reza Oliyai is often cited by papers focused on Protein purification and stability (7 papers), HIV/AIDS drug development and treatment (7 papers) and RNA Interference and Gene Delivery (5 papers). Reza Oliyai collaborates with scholars based in United States, Belgium and Australia. Reza Oliyai's co-authors include Jouko Savolainen, Tomi Järvinen, Tycho Heimbach, Doo-Man Oh, Hanna Kumpulainen, Jarkko Rautio, Valentino J. Stella, William A. Lee, Murty N. Arimilli and Kenneth C. Cundy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Reviews Drug Discovery and Advanced Drug Delivery Reviews.

In The Last Decade

Reza Oliyai

19 papers receiving 1.8k citations

Hit Papers

Prodrugs: design and clinical applications 2008 2026 2014 2020 2008 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reza Oliyai United States 13 855 434 327 231 230 21 1.8k
Doo-Man Oh United States 4 588 0.7× 284 0.7× 116 0.4× 186 0.8× 206 0.9× 6 1.3k
Hanna Kumpulainen Finland 5 601 0.7× 305 0.7× 126 0.4× 170 0.7× 206 0.9× 8 1.3k
Antonio Garofalo Italy 31 1.2k 1.4× 1.2k 2.8× 165 0.5× 531 2.3× 198 0.9× 119 3.2k
Marlene Lúcio Portugal 30 1.5k 1.8× 385 0.9× 119 0.4× 226 1.0× 420 1.8× 91 2.9k
John M. Hilfinger United States 22 641 0.7× 175 0.4× 297 0.9× 507 2.2× 84 0.4× 44 1.5k
Gus R. Rosania United States 22 784 0.9× 120 0.3× 178 0.5× 287 1.2× 102 0.4× 68 1.9k
Anand K. Kondapi India 30 896 1.0× 574 1.3× 137 0.4× 351 1.5× 292 1.3× 79 2.1k
Mehran Yazdanian United States 20 572 0.7× 291 0.7× 128 0.4× 491 2.1× 122 0.5× 32 2.1k
Prashant S. Kharkar India 25 705 0.8× 465 1.1× 134 0.4× 143 0.6× 134 0.6× 83 1.6k
Rosanna Filosa Italy 30 796 0.9× 732 1.7× 96 0.3× 253 1.1× 125 0.5× 83 2.4k

Countries citing papers authored by Reza Oliyai

Since Specialization
Citations

This map shows the geographic impact of Reza Oliyai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reza Oliyai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reza Oliyai more than expected).

Fields of papers citing papers by Reza Oliyai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reza Oliyai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reza Oliyai. The network helps show where Reza Oliyai may publish in the future.

Co-authorship network of co-authors of Reza Oliyai

This figure shows the co-authorship network connecting the top 25 collaborators of Reza Oliyai. A scholar is included among the top collaborators of Reza Oliyai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reza Oliyai. Reza Oliyai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lynch, Patrick M., et al.. (2024). Acceleration of new medicines–CMC lessons learned from emergency use authorizations. SHILAP Revista de lepidopterología. 10(1).
2.
Oliyai, Reza, et al.. (2022). The making of the one pill—Developing single tablet regimens for HIV and for HCV. Antiviral Therapy. 27(2). 191793366–191793366.
3.
Oliyai, Reza, Marcus E. Brewster, Tetsuya Ozeki, Roger A. Rajewski, & William N. Charman. (2012). Professor Valentino J. Stella: Scientist, Mentor, Entrepreneur, Family Man, and Giant in Pharmaceutical Chemistry. Journal of Pharmaceutical Sciences. 101(9). 2989–2995. 1 indexed citations
4.
Rautio, Jarkko, Hanna Kumpulainen, Tycho Heimbach, et al.. (2008). Prodrugs: design and clinical applications. Nature Reviews Drug Discovery. 7(3). 255–270. 1236 indexed citations breakdown →
5.
Stella, Valentino J., Jefferson Tilley, Reza Oliyai, et al.. (2007). Prodrugs. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 89 indexed citations
6.
Oliyai, Reza, Murty N. Arimilli, Robert J. Jones, & William A. Lee. (2001). PHARMACOKINETICS OF SALICYLATE ESTER PRODRUGS OF CYCLIC HPMPC IN DOGS. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 1411–1414. 8 indexed citations
7.
Oliyai, Reza, et al.. (2001). KINETIC STUDIES OF THE DEGRADATION OF OXYCARBONYLOXYMETHYL PRODRUG OF ADEFOVIR AND TENOFOVIR IN SOLUTION. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 1295–1298. 5 indexed citations
8.
Yuan, Lung‐Chi, et al.. (2001). Degradation Kinetics of Oxycarbonyloxymethyl Prodrugs of Phosphonates in Solution. Pharmaceutical Research. 18(2). 234–237. 27 indexed citations
9.
Oliyai, Reza, et al.. (1999). Aryl Ester Prodrugs of Cyclic HPMPC. I: Physicochemical Characterization and In Vitro Biological Stability. Pharmaceutical Research. 16(11). 1687–1693. 18 indexed citations
11.
Oliyai, Reza, et al.. (1998). Biexponential Decomposition of a Neuraminidase Inhibitor Prodrug (GS-4104) in Aqueous Solution. Pharmaceutical Research. 15(8). 1300–1304. 9 indexed citations
12.
Shaw, Jeng‐Pyng, Reza Oliyai, William A. Lee, et al.. (1997). Metabolism and Pharmacokinetics of Novel Oral Prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in Dogs. Pharmaceutical Research. 14(12). 1824–1829. 102 indexed citations
13.
Dougherty, Joseph P., Andrew Mulato, Reza Oliyai, et al.. (1997). Synthesis, in Vitro Biological Evaluation and Oral Bioavailability of 9-[2-(Phosphonomethoxy)Propyl]Adenine (PMPA) Prodrugs. Antiviral chemistry & chemotherapy. 8(6). 557–564. 95 indexed citations
14.
Oliyai, Reza. (1996). Prodrugs of peptides and peptidomimetics for improved formulation and delivery. Advanced Drug Delivery Reviews. 19(2). 275–286. 37 indexed citations
15.
Oliyai, Reza, Teruna J. Siahaan, & V.J. Stella. (1995). The Importance of Structural Factors on the Rate and the Extent of N,O-acyl Migration in Cyclic and Linear Peptides. Pharmaceutical Research. 12(3). 323–328. 12 indexed citations
16.
Oliyai, Reza, et al.. (1994). Kinetics of acid‐catalyzed degradation of cyclosporin A and its analogs in aqueous solution. International journal of peptide & protein research. 43(3). 239–247. 16 indexed citations
17.
Oliyai, Reza, et al.. (1993). Phosphoryloxymethyl Carbamates and Carbonates—Novel Water-Soluble Prodrugs for Amines and Hindered Alcohols. Pharmaceutical Research. 10(9). 1350–1355. 37 indexed citations
18.
Oliyai, Reza & Valentino J. Stella. (1993). Prodrugs of Peptides and Proteins for Improved Formulation and Delivery. The Annual Review of Pharmacology and Toxicology. 33(1). 521–544. 57 indexed citations
19.
Oliyai, Reza & Valentino J. Stella. (1992). Kinetics and Mechanism of Isomerization of Cyclosporin A. Pharmaceutical Research. 9(5). 617–622. 27 indexed citations
20.
Oliyai, Reza & Siegfried Lindenbaum. (1991). Stability testing of pharmaceuticals by isothermal heat conduction calorimetry: Ampicillin in aqueous solution. International Journal of Pharmaceutics. 73(1). 33–36. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026